Related references
Note: Only part of the references are listed.Performance of Management Strategies With Class I Recommendations Among Patients Hospitalized With ST-Segment Elevation Myocardial Infarction in China
Yongchen Hao et al.
JAMA CARDIOLOGY (2022)
Phenylacetylglutamine is associated with the degree of coronary atherosclerotic severity assessed by coronary computed tomographic angiography in patients with suspected coronary artery disease
Yang Liu et al.
ATHEROSCLEROSIS (2021)
Trimethylamine N-oxide is associated with coronary atherosclerotic burden in non-ST-segment myocardial infarction patients: SZ-NSTEMI prospective cohort study
Khalid Bin Waleed et al.
REVIEWS IN CARDIOVASCULAR MEDICINE (2021)
Percent atheroma volume: Optimal variable to report whole-heart atherosclerotic plaque burden with coronary CTA, the PARADIGM study
Alexander R. van Rosendael et al.
JOURNAL OF CARDIOVASCULAR COMPUTED TOMOGRAPHY (2020)
A Cardiovascular Disease-Linked Gut Microbial Metabolite Acts via Adrenergic Receptors
Ina Nemet et al.
CELL (2020)
A Quantile-Based g-Computation Approach to Addressing the Effects of Exposure Mixtures
Alexander P. Keil et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2020)
Plasma Trimethylamine N-Oxide and Risk of Cardiovascular Events in Patients With Type 2 Diabetes
Mikael Croyal et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Gut microbe-derived metabolite trimethylamine N-oxide induces cardiac hypertrophy and fibrosis
Zehua Li et al.
LABORATORY INVESTIGATION (2019)
Angiographic features of patients with coronary plaque erosion
Hyung Oh Kim et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2019)
A guide for Gensini Score calculation
Georgios P. Rampidis et al.
ATHEROSCLEROSIS (2019)
Trimethyllysine, a trimethylamine N-oxide precursor, provides near- and long-term prognostic value in patients presenting with acute coronary syndromes
Xinmin S. Li et al.
EUROPEAN HEART JOURNAL (2019)
Mon2 predicts poor outcome in ST-elevation myocardial infarction
E. Shantsila et al.
JOURNAL OF INTERNAL MEDICINE (2019)
Circulating trimethylamine N-oxide and the risk of cardiovascular diseases: a systematic review and meta-analysis of 11 prospective cohort studies
Jiaqian Qi et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
Conceptual Framework for Addressing Residual Atherosclerotic Cardiovascular Disease Risk in the Era of Precision Medicine
Kershaw V. Patel et al.
CIRCULATION (2018)
Plasma trimethylamine N-oxide is associated with vulnerable plaque characteristics in CAD patients as assessed by optical coherence tomography
Xinxin Liu et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
Microbial modulation of cardiovascular disease
J. Mark Brown et al.
NATURE REVIEWS MICROBIOLOGY (2018)
Untargeted metabolomics identifies trimethyllysine, a TMAO-producing nutrient precursor, as a predictor of incident cardiovascular disease risk
Xinmin S. Li et al.
JCI INSIGHT (2018)
Increased Trimethylamine N-Oxide Portends High Mortality Risk Independent of Glycemic Control in Patients with Type 2 Diabetes Mellitus
W. H. Wilson Tang et al.
CLINICAL CHEMISTRY (2017)
Trimethylamine N-oxide and Risk Stratification after Acute Myocardial Infarction
Toru Suzuki et al.
CLINICAL CHEMISTRY (2017)
Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis
Gabriele Giacomo Schiattarella et al.
EUROPEAN HEART JOURNAL (2017)
Role of uremic toxin indoxyl sulfate in the progression of cardiovascular disease
Huichang Gao et al.
LIFE SCIENCES (2017)
Trimethylamine N-oxide impairs pyruvate and fatty acid oxidation in cardiac mitochondria
Marina Makrecka-Kuka et al.
TOXICOLOGY LETTERS (2017)
The gut microbiome, diet, and links to cardiometabolic and chronic disorders
Judith Aron-Wisnewsky et al.
NATURE REVIEWS NEPHROLOGY (2016)
Trimethylamine N-oxide induces inflammation and endothelial dysfunction in human umbilical vein endothelial cells via activating ROS-TXNIP-NLRP3 inflammasome
Xiaolei Sun et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk
Weifei Zhu et al.
CELL (2016)
Plasma Trimethylamine N-Oxide, a Gut Microbe-Generated Phosphatidylcholine Metabolite, Is Associated With Atherosclerotic Burden
Vichai Senthong et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Microbiota-Derived Phenylacetylglutamine Associates with Overall Mortality and Cardiovascular Disease in Patients with CKD
Ruben Poesen et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
The Relationship Between Trimethylamine-N-Oxide and Prevalent Cardiovascular Disease in a Multiethnic Population Living in Canada
Andrew Mente et al.
CANADIAN JOURNAL OF CARDIOLOGY (2015)
Coronary severity score and C-reactive protein predict major adverse cardiovascular events in patients with stable coronary artery disease (from the Taichung CAD study)
Hung-Chih Pan et al.
CLINICA CHIMICA ACTA (2015)
Gut Microbiota-Dependent Trimethylamine N-Oxide (TMAO) Pathway Contributes to Both Development of Renal Insufficiency and Mortality Risk in Chronic Kidney Disease
W. H. Wilson Tang et al.
CIRCULATION RESEARCH (2015)
Measurement of trimethylamine-N-oxide by stable isotope dilution liquid chromatography tandem mass spectrometry
Zeneng Wang et al.
ANALYTICAL BIOCHEMISTRY (2014)
Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide
Zeneng Wang et al.
EUROPEAN HEART JOURNAL (2014)
Prognostic Utility of BCIS Myocardial Jeopardy Score for Classification of Coronary Disease Burden and Completeness of Revascularization
Kalpa De Silva et al.
AMERICAN JOURNAL OF CARDIOLOGY (2013)
Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial
Friedrich W. Mohr et al.
LANCET (2013)
Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis
Robert A. Koeth et al.
NATURE MEDICINE (2013)
Intestinal Microbial Metabolism of Phosphatidylcholine and Cardiovascular Risk
W. H. Wilson Tang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Association of coronary atherosclerotic burden with clinical presentation and prognosis in patients with stable and unstable coronary artery disease
Gjin Ndrepepa et al.
CLINICAL RESEARCH IN CARDIOLOGY (2012)
A complex microworld in the gut Gut microbiota and cardiovascular disease connectivity
Michael R. Howitt et al.
NATURE MEDICINE (2012)
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Zeneng Wang et al.
NATURE (2011)
Serum Indoxyl Sulfate Is Associated with Vascular Disease and Mortality in Chronic Kidney Disease Patients
Fellype C. Barreto et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease
Patrick W. Serruys et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Universal definition of myocardial infarction
Kristian Thygesen et al.
CIRCULATION (2007)
Share Paper
